The encapsulation strategy to improve the survival of probiotics for food application: from rough multicellular to single-cell surface engineering and microbial mediation
However, the percentage varies with every injection
This gap has attracted compounding pharmacies, who mix and modify approved drugs to cater to individual needs
The ethical aspects related to the weight-loss programs with the use of telehealth are proper patient selection, preventing unnecessary prescribing, and the explanation of risks and benefits
A 2025 review in Mayo Clinic Proceedings reports that 40% to 70% of patients on these medications experience gastrointestinal side effects, and that first-line management is dietary: smaller and more frequent meals, adequate hydration, and steering clear of high-fat and high-sugar foods
The proportion of prescribing Saxenda (liraglutide approved for weight management) dropped from 79% in 2018 to 9% in 2023 while in 2023 Wegovy (recieved FDA approval in 2020) was prescribed for 60% of GLP-1 RA users in non-diabetics with obesity/overweight diagnosis